Sarah A Wernimont

Sarah A Wernimont is an Assistant Professor at the University of Minnesota within the Department of Obstetrics, Gynecology and Women's Health, specializing in Maternal Fetal Medicine. Her work integrates clinical practice with scientific research, focusing on the intersection of placental biology, metabolic regulation, and pregnancy complications.

Dr. Wernimont's research interests center on mitochondrial metabolism in trophoblast differentiation, diabetes management during pregnancy, obstetric anesthesia considerations, and improving maternal outcomes through technological interventions. She explores how cellular nutrient sensing impacts fetal growth and investigates innovative approaches to enhance glucose monitoring adherence.

Recent publications highlight trends across maternal-fetal medicine, metabolic regulation in pregnancy, and clinical implementation science. Her article series on cellular-enabled glucometers (2018-2022) demonstrates commitment to digital health solutions, while 2023-2025 studies on mitochondrial citrate flux and trophoblast differentiation reveal molecular mechanisms underlying placental development.

As principal investigator, Dr. Wernimont leads NIH-funded projects including "Mitochondrial nutrient transport and trophoblast differentiation" (2024-2029) and prior ABOG Development Program grants (2022-2024). She collaborates with experts in reproductive metabolism, fetal development, and maternal-fetal medicine across institutions like Duke University and the University of Missouri.